Report Detail
Global RLT Therapy Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4742109 |
- 28 September, 2026 |
- Global |
- 83 Pages |
- GIR |
- Service & Software
According to our (Global Info Research) latest study, the global RLT Therapy market size was valued at US$ 3131 million in 2025 and is forecast to a readjusted size of US$ 6409 million by 2032 with a CAGR of 10.7% during review period.
Radioligand therapy is an advanced targeted cancer treatment method. Its core principle involves precisely delivering a cell-killing radionuclide to the lesion via a precisely designed "biological missile"—a ligand molecule that specifically recognizes markers on the surface of tumor cells. This design achieves cellular-level precision delivery, similar to internal radiation therapy: the radionuclide releases high-energy rays locally on the tumor, destroying the DNA of cancer cells while maximally protecting surrounding healthy tissue due to its extremely short radiation range. This therapy typically follows a "therapeutic approach," first using paired drugs with conjugated diagnostic radionuclides to perform imaging examinations to screen suitable patients and assess target expression levels, thus achieving truly personalized precision medicine.
Radioligand therapy shows great promise, evolving from a specialty therapy targeting a few specific targets into one of the core pillars of oncology. Its growth is driven by multiple factors: First, the range of targets is constantly expanding, moving from mature targets like PSMA and SSTR to new targets such as FAP and CDH6, covering a wider range of solid tumors beyond prostate cancer and neuroendocrine tumors. Second, radionuclide innovation is accelerating, with alpha radionuclide therapy becoming a research hotspot due to its stronger killing power and precision, and holding promise for treating more advanced or drug-resistant patients. In the future, "integrated diagnosis and treatment" will become the standard paradigm, driving precise pre-treatment screening and real-time monitoring of efficacy.
Report Scope
This report is a detailed and comprehensive analysis for global RLT Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Types of Radiation and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global RLT Therapy market size and forecasts, in consumption value ($ Million), 2021-2032
Global RLT Therapy market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global RLT Therapy market size and forecasts, by Types of Radiation and by Application, in consumption value ($ Million), 2021-2032
Global RLT Therapy market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for RLT Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global RLT Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Lilly, Telix Pharmaceuticals, ITM Isotope Technologies Munich, Curium Pharma, Bristol Myers Squibb, AstraZeneca, POINT Biopharma, Orano Med, RadioMedix, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
RLT Therapy market is split by Types of Radiation and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Types of Radiation and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Types of Radiation
Beta Particle Therapy
Alpha Particle Therapy
Auger Electron Therapy
Market segment by Primary Targets
PSMA
SSTR
Others
Market segment by Treatment Strategies
Integrated Therapy
Standalone Treatment
Market segment by Application
Prostate Cancer Related
Neuroendocrine Tumors
Market segment by players, this report covers
Novartis
Lilly
Telix Pharmaceuticals
ITM Isotope Technologies Munich
Curium Pharma
Bristol Myers Squibb
AstraZeneca
POINT Biopharma
Orano Med
RadioMedix
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe RLT Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of RLT Therapy, with revenue, gross margin, and global market share of RLT Therapy from 2021 to 2026.
Chapter 3, the RLT Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Types of Radiation and by Application, with consumption value and growth rate by Types of Radiation, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and RLT Therapy market forecast, by regions, by Types of Radiation and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of RLT Therapy.
Chapter 13, to describe RLT Therapy research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of RLT Therapy by Types of Radiation
- 1.3.1 Overview: Global RLT Therapy Market Size by Types of Radiation: 2021 Versus 2025 Versus 2032
- 1.3.2 Global RLT Therapy Consumption Value Market Share by Types of Radiation in 2025
- 1.3.3 Beta Particle Therapy
- 1.3.4 Alpha Particle Therapy
- 1.3.5 Auger Electron Therapy
- 1.4 Classification of RLT Therapy by Primary Targets
- 1.4.1 Overview: Global RLT Therapy Market Size by Primary Targets: 2021 Versus 2025 Versus 2032
- 1.4.2 Global RLT Therapy Consumption Value Market Share by Primary Targets in 2025
- 1.4.3 PSMA
- 1.4.4 SSTR
- 1.4.5 Others
- 1.5 Classification of RLT Therapy by Treatment Strategies
- 1.5.1 Overview: Global RLT Therapy Market Size by Treatment Strategies: 2021 Versus 2025 Versus 2032
- 1.5.2 Global RLT Therapy Consumption Value Market Share by Treatment Strategies in 2025
- 1.5.3 Integrated Therapy
- 1.5.4 Standalone Treatment
- 1.6 Global RLT Therapy Market by Application
- 1.6.1 Overview: Global RLT Therapy Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Prostate Cancer Related
- 1.6.3 Neuroendocrine Tumors
- 1.7 Global RLT Therapy Market Size & Forecast
- 1.8 Global RLT Therapy Market Size and Forecast by Region
- 1.8.1 Global RLT Therapy Market Size by Region: 2021 VS 2025 VS 2032
- 1.8.2 Global RLT Therapy Market Size by Region, (2021-2032)
- 1.8.3 North America RLT Therapy Market Size and Prospect (2021-2032)
- 1.8.4 Europe RLT Therapy Market Size and Prospect (2021-2032)
- 1.8.5 Asia-Pacific RLT Therapy Market Size and Prospect (2021-2032)
- 1.8.6 South America RLT Therapy Market Size and Prospect (2021-2032)
- 1.8.7 Middle East & Africa RLT Therapy Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Novartis
- 2.1.1 Novartis Details
- 2.1.2 Novartis Major Business
- 2.1.3 Novartis RLT Therapy Product and Solutions
- 2.1.4 Novartis RLT Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Novartis Recent Developments and Future Plans
- 2.2 Lilly
- 2.2.1 Lilly Details
- 2.2.2 Lilly Major Business
- 2.2.3 Lilly RLT Therapy Product and Solutions
- 2.2.4 Lilly RLT Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Lilly Recent Developments and Future Plans
- 2.3 Telix Pharmaceuticals
- 2.3.1 Telix Pharmaceuticals Details
- 2.3.2 Telix Pharmaceuticals Major Business
- 2.3.3 Telix Pharmaceuticals RLT Therapy Product and Solutions
- 2.3.4 Telix Pharmaceuticals RLT Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Telix Pharmaceuticals Recent Developments and Future Plans
- 2.4 ITM Isotope Technologies Munich
- 2.4.1 ITM Isotope Technologies Munich Details
- 2.4.2 ITM Isotope Technologies Munich Major Business
- 2.4.3 ITM Isotope Technologies Munich RLT Therapy Product and Solutions
- 2.4.4 ITM Isotope Technologies Munich RLT Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 ITM Isotope Technologies Munich Recent Developments and Future Plans
- 2.5 Curium Pharma
- 2.5.1 Curium Pharma Details
- 2.5.2 Curium Pharma Major Business
- 2.5.3 Curium Pharma RLT Therapy Product and Solutions
- 2.5.4 Curium Pharma RLT Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Curium Pharma Recent Developments and Future Plans
- 2.6 Bristol Myers Squibb
- 2.6.1 Bristol Myers Squibb Details
- 2.6.2 Bristol Myers Squibb Major Business
- 2.6.3 Bristol Myers Squibb RLT Therapy Product and Solutions
- 2.6.4 Bristol Myers Squibb RLT Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Bristol Myers Squibb Recent Developments and Future Plans
- 2.7 AstraZeneca
- 2.7.1 AstraZeneca Details
- 2.7.2 AstraZeneca Major Business
- 2.7.3 AstraZeneca RLT Therapy Product and Solutions
- 2.7.4 AstraZeneca RLT Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 AstraZeneca Recent Developments and Future Plans
- 2.8 POINT Biopharma
- 2.8.1 POINT Biopharma Details
- 2.8.2 POINT Biopharma Major Business
- 2.8.3 POINT Biopharma RLT Therapy Product and Solutions
- 2.8.4 POINT Biopharma RLT Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 POINT Biopharma Recent Developments and Future Plans
- 2.9 Orano Med
- 2.9.1 Orano Med Details
- 2.9.2 Orano Med Major Business
- 2.9.3 Orano Med RLT Therapy Product and Solutions
- 2.9.4 Orano Med RLT Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Orano Med Recent Developments and Future Plans
- 2.10 RadioMedix
- 2.10.1 RadioMedix Details
- 2.10.2 RadioMedix Major Business
- 2.10.3 RadioMedix RLT Therapy Product and Solutions
- 2.10.4 RadioMedix RLT Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 RadioMedix Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global RLT Therapy Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of RLT Therapy by Company Revenue
- 3.2.2 Top 3 RLT Therapy Players Market Share in 2025
- 3.2.3 Top 6 RLT Therapy Players Market Share in 2025
- 3.3 RLT Therapy Market: Overall Company Footprint Analysis
- 3.3.1 RLT Therapy Market: Region Footprint
- 3.3.2 RLT Therapy Market: Company Product Type Footprint
- 3.3.3 RLT Therapy Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Types of Radiation
- 4.1 Global RLT Therapy Consumption Value and Market Share by Types of Radiation (2021-2026)
- 4.2 Global RLT Therapy Market Forecast by Types of Radiation (2027-2032)
5 Market Size Segment by Application
- 5.1 Global RLT Therapy Consumption Value Market Share by Application (2021-2026)
- 5.2 Global RLT Therapy Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America RLT Therapy Consumption Value by Types of Radiation (2021-2032)
- 6.2 North America RLT Therapy Market Size by Application (2021-2032)
- 6.3 North America RLT Therapy Market Size by Country
- 6.3.1 North America RLT Therapy Consumption Value by Country (2021-2032)
- 6.3.2 United States RLT Therapy Market Size and Forecast (2021-2032)
- 6.3.3 Canada RLT Therapy Market Size and Forecast (2021-2032)
- 6.3.4 Mexico RLT Therapy Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe RLT Therapy Consumption Value by Types of Radiation (2021-2032)
- 7.2 Europe RLT Therapy Consumption Value by Application (2021-2032)
- 7.3 Europe RLT Therapy Market Size by Country
- 7.3.1 Europe RLT Therapy Consumption Value by Country (2021-2032)
- 7.3.2 Germany RLT Therapy Market Size and Forecast (2021-2032)
- 7.3.3 France RLT Therapy Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom RLT Therapy Market Size and Forecast (2021-2032)
- 7.3.5 Russia RLT Therapy Market Size and Forecast (2021-2032)
- 7.3.6 Italy RLT Therapy Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific RLT Therapy Consumption Value by Types of Radiation (2021-2032)
- 8.2 Asia-Pacific RLT Therapy Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific RLT Therapy Market Size by Region
- 8.3.1 Asia-Pacific RLT Therapy Consumption Value by Region (2021-2032)
- 8.3.2 China RLT Therapy Market Size and Forecast (2021-2032)
- 8.3.3 Japan RLT Therapy Market Size and Forecast (2021-2032)
- 8.3.4 South Korea RLT Therapy Market Size and Forecast (2021-2032)
- 8.3.5 India RLT Therapy Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia RLT Therapy Market Size and Forecast (2021-2032)
- 8.3.7 Australia RLT Therapy Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America RLT Therapy Consumption Value by Types of Radiation (2021-2032)
- 9.2 South America RLT Therapy Consumption Value by Application (2021-2032)
- 9.3 South America RLT Therapy Market Size by Country
- 9.3.1 South America RLT Therapy Consumption Value by Country (2021-2032)
- 9.3.2 Brazil RLT Therapy Market Size and Forecast (2021-2032)
- 9.3.3 Argentina RLT Therapy Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa RLT Therapy Consumption Value by Types of Radiation (2021-2032)
- 10.2 Middle East & Africa RLT Therapy Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa RLT Therapy Market Size by Country
- 10.3.1 Middle East & Africa RLT Therapy Consumption Value by Country (2021-2032)
- 10.3.2 Turkey RLT Therapy Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia RLT Therapy Market Size and Forecast (2021-2032)
- 10.3.4 UAE RLT Therapy Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 RLT Therapy Market Drivers
- 11.2 RLT Therapy Market Restraints
- 11.3 RLT Therapy Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 RLT Therapy Industry Chain
- 12.2 RLT Therapy Upstream Analysis
- 12.3 RLT Therapy Midstream Analysis
- 12.4 RLT Therapy Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on RLT Therapy. Industry analysis & Market Report on RLT Therapy is a syndicated market report, published as Global RLT Therapy Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of RLT Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
